| European Case Law Identifier: | ECLI:EP:BA:2014:T157009.20140516 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 16 May 2014 | ||||||||
| Case number: | T 1570/09 | ||||||||
| Application number: | 05752599.0 | ||||||||
| IPC class: | A61K 31/194 A61K 31/198 A61P 3/06 A61K 38/03 A61K 31/16 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | USE OF ALPHA-KETOGLUTARATE AND RELATED COMPOUNDS FOR LOWERING PLASMA LIPIDS | ||||||||
| Applicant name: | Protista Biotechnology AB | ||||||||
| Opponent name: | - | ||||||||
| Board: | 3.3.02 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: | |||||||||
| Keywords: | Admission of main request and first auxiliary request (Yes) Main request: Two independent claims for the same medical use;one claim under the provisions of EPC 1973 invoking legal fiction in G 5/83, and other claim under the provisions of Article 54(5) EPC 2000 (No) First auxiliary request: allowable (Yes) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t091570eu1.html
Date retrieved: 17 May 2021